Menu
GeneBe

19-17817059-C-A

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PP3BS2

The NM_005543.4(INSL3):c.191G>T(p.Arg64Leu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000391 in 1,612,712 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R64P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00027 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000015 ( 0 hom. )

Consequence

INSL3
NM_005543.4 missense, splice_region

Scores

6
11
Splicing: ADA: 0.9909
2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 1.25
Variant links:
Genes affected
INSL3 (HGNC:6086): (insulin like 3) This gene encodes a member of the insulin-like hormone superfamily. The encoded protein is mainly produced in gonadal tissues. Studies of the mouse counterpart suggest that this gene may be involved in the development of urogenital tract and female fertility. This protein may also act as a hormone to regulate growth and differentiation of gubernaculum, and thus mediating intra-abdominal testicular descent. Mutations in this gene may lead to cryptorchidism. Alternate splicing results in multiple transcript variants. [provided by RefSeq, May 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF. Scorers claiming Uncertain: max_spliceai. No scorers claiming Benign.
BS2
High AC in GnomAd at 41 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
INSL3NM_005543.4 linkuse as main transcriptc.191G>T p.Arg64Leu missense_variant, splice_region_variant 2/2 ENST00000317306.8
INSL3NM_001265587.2 linkuse as main transcriptc.286G>T p.Val96Leu missense_variant, splice_region_variant 3/3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
INSL3ENST00000598577.1 linkuse as main transcriptc.213G>T p.Arg71Ser missense_variant 2/21
INSL3ENST00000317306.8 linkuse as main transcriptc.191G>T p.Arg64Leu missense_variant, splice_region_variant 2/21 NM_005543.4 P1P51460-1
INSL3ENST00000379695.5 linkuse as main transcriptc.286G>T p.Val96Leu missense_variant, splice_region_variant 3/31 P51460-2

Frequencies

GnomAD3 genomes
AF:
0.000269
AC:
41
AN:
152182
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.0000649
AC:
16
AN:
246658
Hom.:
0
AF XY:
0.0000374
AC XY:
5
AN XY:
133728
show subpopulations
Gnomad AFR exome
AF:
0.000992
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000151
AC:
22
AN:
1460412
Hom.:
0
Cov.:
31
AF XY:
0.0000124
AC XY:
9
AN XY:
726508
show subpopulations
Gnomad4 AFR exome
AF:
0.000597
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000166
GnomAD4 genome
AF:
0.000269
AC:
41
AN:
152300
Hom.:
0
Cov.:
31
AF XY:
0.000282
AC XY:
21
AN XY:
74472
show subpopulations
Gnomad4 AFR
AF:
0.000962
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.000102
Hom.:
0
Bravo
AF:
0.000208
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000906
AC:
11

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Cryptorchidism Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingVictorian Clinical Genetics Services, Murdoch Childrens Research InstituteMay 06, 2021Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as 3B-VUS. Following criteria are met: 0105 - The mechanism of disease for this gene is not clearly established. (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from arginine to leucine. (I) 0219 - This variant encodes a different missense (NM_001265587.1(INSL3):c.286G>T; p.(Val96Leu)) in an alternative transcript, due to alternative exon splicing leading to a shifted reading frame. (I) 0251 - This variant is heterozygous. (I) 0302 - Variant is present in gnomAD (v3) <0.001 for a dominant condition (39 heterozygotes, 0 homozygotes). (SP) 0309 - An alternative amino acid change at the same position has been observed in gnomAD (v2) (1 heterozygote, 0 homozygotes). (I) 0600 - Variant is located in the annotated IlGF relaxin like domain (NCBI). (I) 0502 - Missense variant with conflicting in silico predictions and uninformative conservation. (I) 0705 - No comparable missense variants have previous evidence for pathogenicity. (I) 0807 - This variant has no previous evidence of pathogenicity. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 13, 2021The c.191G>T (p.R64L) alteration is located in exon 2 (coding exon 2) of the INSL3 gene. This alteration results from a G to T substitution at nucleotide position 191, causing the arginine (R) at amino acid position 64 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.24
BayesDel_addAF
Benign
-0.099
T
BayesDel_noAF
Benign
-0.31
Cadd
Uncertain
24
Dann
Uncertain
0.99
DEOGEN2
Benign
0.37
T
Eigen
Benign
0.037
Eigen_PC
Benign
-0.026
FATHMM_MKL
Uncertain
0.77
D
LIST_S2
Benign
0.65
T
M_CAP
Uncertain
0.085
D
MetaRNN
Benign
0.13
T
MetaSVM
Benign
-0.94
T
MutationTaster
Benign
0.95
N;N
PROVEAN
Benign
-1.5
N
REVEL
Uncertain
0.40
Sift
Uncertain
0.018
D
Sift4G
Uncertain
0.038
D
Polyphen
0.71
P
Vest4
0.34
MVP
0.90
ClinPred
0.82
D
GERP RS
2.7
Varity_R
0.15

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
0.99
dbscSNV1_RF
Pathogenic
0.87
SpliceAI score (max)
0.41
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.41
Position offset: 22
DS_AL_spliceai
0.29
Position offset: 0

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs151110387; hg19: chr19-17927868; API